The U.S. Supreme Court’s ruling that President Trump’s emergency tariffs are illegal just birthed one of the most compelling distressed asset classes of 2026.
While the high court struck down the tariffs, it did not explicitly order the immediate refund of the estimated $175 billion the government has collected since last February. This legal gray area has triggered a massive gold rush for litigation finance and special situations investors.
💸 THE SECONDARY MARKET BOOM: Importers are hedging their bets by selling the rights to their potential government refunds to outside investors for a fraction of the face value.
- The Surge: Before the ruling, claims tied to fentanyl tariffs were trading at a steep discount of 16-17%, while reciprocal tariff claims traded at 26-28%.
- The Convergence: Following Friday’s decision, the distinction between the two has collapsed, and prices for these refund rights have surged into the 40-50% range.
🛡️ THE UNCORRELATED ASSET: Why are distressed debt and special situations funds swarming this opaque market?
- Zero Market Correlation: The payout on these assets is completely divorced from equity volatility, interest rates, or broader macroeconomic trends. It is a pure legal and political risk play.
- The Discount Rationale: Prices are capping out at 50% because the administration has made it clear they intend to fight the refunds tooth and nail. Investors are pricing in a protracted, complex legal battle.
💡 ANALYST TAKEAWAY: This is a textbook litigation finance arbitrage. For corporations, selling these claims at 45% represents found money—a way to instantly monetize an asset they had already written off. For special situations investors, it represents a massive opportunity. If funds have the legal firepower and the duration capital to outlast the administration in court, buying into a $175 billion total addressable market at a 50% discount offers exceptional, uncorrelated upside.
👇 Special Situations Investors & Litigation Funders: Are you buying these claims at the current 40-50% valuation, or is the political risk of the administration stalling the payouts too high?